Marie-Hermine de Montangon

Public Notice: Important Update on Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25% w/v As per File No. SND/MA/22/000301, the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), has issued a notification regarding misleading claims made about Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25% w/v. Please note: - This product is only approved for the treatment of Presbyopia in adults. - Claims that it can reduce the need for reading glasses or enhance near vision within 15 minutes are unapproved and misleading. Stay cautious and rely on accurate, approved information for your healthcare needs. || Indian Pharmaceutical Association || #PublicNotice #HealthAwareness #CDSCO #EyeHealth #PilocarpineHydrochloride #PresbyopiaTreatment #StayInformed #HealthcareUpdates #ConsumerSafety #DrugSafety

17

Road to Disaster: Lack of Robust Preparedness is Causing Loss of Lives and Infrastructure in Nepal https://lnkd.in/dQqTzGqQ Bhagirathi Pandit

2

How to translate documents for National Health Service (NHS) https://lnkd.in/dpSitdsY #howtotranslatedocumentsfornationalhealthservice

1

The 𝗣𝗮𝗸𝗶𝘀𝘁𝗮𝗻𝗶 𝗔𝗶𝗿 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗘𝘅𝗽𝗲𝗿𝘁𝘀 (𝗣𝗔𝗤𝘅) 𝗴𝗿𝗼𝘂𝗽 has issued a statement on the Punjab government’s response and planning on dealing with 🟤 Hazardous #AirQuality in the province and expounded to declare this a regional #PublicHealth crisis. The group has further asked the government, in light of the new 𝘈𝘳𝘵𝘪𝘤𝘭𝘦 9𝘈 𝘰𝘧 𝘵𝘩𝘦 𝘊𝘰𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘪𝘰𝘯, to safeguard people’s health and conduct public consultations on any further policies and plans concerning #AirPollution. Read below:

24

1 commentaire

📰 Read the #IDDI's latest blog: https://lnkd.in/d7ffNJJc written by Emmanuel Quinaux, Director Biostatistical Services and Sarah Hale, PhD, Associate Director Biostatistical Services! In this blog, we’ll explore the significance of integrating #IDDI's Consultancy, Biostatistical, and Data Management services to ensure significantly the achievement of your study's goals effectively. #biometricscro #biostatistics #trialdesign #strategyconsulting #clinicaltrials #clinicalstudy #clinicalresearch #clinicaldatamanagement

20

CPC Central Committee adopts resolution on further deepening reform comprehensively https://lnkd.in/gECUUeUS

6

The Central Consumer Protection Authority (CCPA) has issued guidelines to provide for the prevention of misleading advertisements in the coaching sector. All forms of misleading advertisements, including false claims on the courses offered, selection of candidates, ranks, job security, admissions, false sense of urgency or scarcity, etc., have been addressed. Candidates consent to sharing photos, testimonials, etc. after selection is a notable direction. Notably, the ministry of education had also issued guidelines in January this year for the regulation of coaching centres to effectively address malpractices adopted by them and protect students’ interests. Read More: https://lnkd.in/gJCMv2Y3 #advertisments #consumerprotection #coachingcentres #legalupdates #india #foxmandal

6

SC to Decide on Sampling Procedure in NDPS Cases Spot sampling or Magistrate's supervision? SC examines Section 52A of the NDPS Act to resolve conflicts in drug sampling and disposal procedures. 🔹 Key Issues: 1. Should sampling happen at the recovery site or under Magistrate oversight? 2. Are Standing Order timelines (72 hours) binding? 3. Harmonizing Sections 52A & 55. Verdict awaited. Crucial for evidence integrity in NDPS cases. Click on the 🔗 link 👇 🖇️ https://lnkd.in/gQNTqRnn

1

PNG - Keeping our clients up to date FDA and EMA Guidance Addressing safety concerns and other public health concerns in proposed (invented) Names. Guidelines on the acceptability of names for human medicinal products processed through the centralized procedure (EMA/NRG). It should be noted that the NRG will consider potential for confusion of proposed (invented) names with the (invented) names of authorized, suspended and revoked/withdrawn medicinal products in the different Member States according to the relevant national legislation regardless of the route of authorization. When considering the potential for confusion with the name of a withdrawn/revoked medicinal product the NRG will, prior to assessment, check whether the medicinal product is withdrawn across all EU/EEA countries. If the medicinal product remains authorized in one or more countries, the objection will be considered valid, and the usual similarity assessment will be conducted. The NRG will also consider proposed (invented) names which have been already accepted either by the NRG in the context of the centralized procedure or by a national competent authority (NCA) in any other procedure at national level. Follow PNG to keep informed of FDA & EMA Guidance Need help CALL or email us at: Pharmaceutical Naming Group (PNG) [email protected] PNG Staff are Regulatory SME’s  

2

All About #APSI-India: A Weekly info series. This week, we take you to our website blog article, 'A model for wastewater-based epidemiology and disease surveillance', https://lnkd.in/exdT_Wat written by Dr. Aruna Panda, Program Director, APSI-India. What wastewater surveillance and wastewater-based epidemiology can reveal? A plethora of disease-causing #prioritypathogens, #AMR, detailed genetic makeup, #strains, #lineages, #diseasetrends, #diseaseburden and #healthmeasures for #routineimplementation and data-backed suggestions for policy/action by decision makers! Read along for the #APSI-India's #workstrategies and #keyachievements!! #WWS #WBE #AMR #EnvironmentalSurveillance #highefficiency #lowcost #indigenouskits #technologyforsurveillance #infectioncontrol #earlywarningsystem #publichealthsurveillance #publichealthadvocacy #publichealthpolicy #Outreach For more details, visit #APSI-India's website https://lnkd.in/dnEBuvaa The Rockefeller Foundation

3

Expert evidence from forensic lip reader admitted in Lehrmann defamation trial Yesterday, Lee J admitted evidence adduced by Network Ten from a forensic lip reader. Mr R, a forensic lip reader, had prepared an expert report containing a transcript of what he observed was said by Ms Higgins, Mr Lehrmann and others captured on CCTV footage at The Dock. Mr Lehrmann had unsuccessfully opposed an application made by Network Ten to rely on Mr R’s evidence. You can read our case update on this interlocutory decision of Lee J from our previous post. Mr Lehrmann objected to the evidence on the grounds that it did not meet the gateway of admissibility under s79 of the Evidence Act 1995 (Cth). Giving reasons ex tempore, Lee J accepted that lip reading is not perfect but the guide for admissibility under s 79 of the Act is not a “counsel of perfection”. Read our full update here: https://lnkd.in/dsTcQh6P

12

Developing the best standard of treatment in TB prevention and care means creating regimens that are safe, effective, and accessible for all affected communities that need them. This community and advocate statement from IMPAACT4TB emphasizes the urgency for governments to act on a child-friendly preventive treatment drug. 👇 https://lnkd.in/erPp9qdE

9

The WHO Director-General has declared the ongoing mpox outbreak a Public Health Emergency of International Concern (PHEIC), emphasizing the urgent need for global action. https://lnkd.in/dN45XXQM In response to this global health crisis, Bioer is ready to offer our Nucleic Acid Multiplex Detection Kit (Fluorescent PCR) for the Monkeypox Virus. This advanced diagnostic tool, with its high sensitivity (150 copies/mL) and rapid detection capability within 30 minutes, is designed to meet the urgent demands of the current situation. It targets key genetic markers, F3L (FAM) and B6R (HEX), ensuring precise and reliable results, which are essential for controlling the spread of the virus. As the world grapples with this public health emergency, Bioer remains committed to supporting healthcare providers and public health authorities with cutting-edge molecular diagnostics. Our MPX PCR kit is an essential component in the fight against mpox, aligning with WHO’s global strategy to combat this outbreak. We invite our global partners and healthcare professionals to connect with us and explore how Bioer’s solutions can aid in the rapid detection and control of mpox. [email protected] #Mpox #Monkeypox #PublicHealth #PCR #MolecularDiagnostics #BioerTechnology #GlobalHealth

12